SV2 regulates neurotransmitter release via multiple mechanisms. - Wikidata - awgldk - TriplyDB

SV2 regulates neurotransmitter release via multiple mechanisms.

SV2 regulates neurotransmitter release via multiple mechanisms.

http://www.wikidata.org/entity/Q34304904

about

Epilepsy caused by an abnormal alternative splicing with dosage effect of the SV2A gene in a chicken model Levetiracetam reverses synaptic deficits produced by overexpression of SV2A Exploring the interaction of SV2A with racetams using homology modelling, molecular dynamics and site-directed mutagenesis Familial Dysautonomia (FD) Human Embryonic Stem Cell Derived PNS Neurons Reveal that Synaptic Vesicular and Neuronal Transport Genes Are Directly or Indirectly Affected by IKBKAP Downregulation Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission Modulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays.Cortical Auditory Deafferentation Induces Long-Term Plasticity in the Inferior Colliculus of Adult Rats: Microarray and qPCR Analysis Puzzling Out Synaptic Vesicle 2 Family Members Functions.A presynaptic role for PKA in synaptic tagging and memory.Hierarchical clustering of gene expression patterns in the Eomes + lineage of excitatory neurons during early neocortical development Identification of the antiepileptic racetam binding site in the synaptic vesicle protein 2A by molecular dynamics and docking simulations.Kindling-induced asymmetric accumulation of hippocampal 7S SNARE complexes correlates with enhanced glutamate release.Glycosylation is dispensable for sorting of synaptotagmin 1 but is critical for targeting of SV2 and synaptophysin to recycling synaptic vesicles Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice.Electroporation of the hindbrain to trace axonal trajectories and synaptic targets in the chick embryo A Missense Mutation of the Gene Encoding Synaptic Vesicle Glycoprotein 2A (SV2A) Confers Seizure Susceptibility by Disrupting Amygdalar Synaptic GABA Release.Lamotrigine and levetiracetam exert a similar modulation of TMS-evoked EEG potentials.Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease.Synaptic vesicle protein 2A: basic facts and role in synaptic function.Fruit flies as a powerful model to drive or validate pain genomics efforts.Mechanisms of levetiracetam in the control of status epilepticus and epilepsy.Synaptic vesicle protein 2b is expressed temporospatially in (pre)odontoblasts in developing molars.Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease.A comparison of four antiepileptic drugs in status epilepticus: experience from India.Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.Differentiated Human SH-SY5Y Cells Provide a Reductionist Model of Herpes Simplex Virus 1 Neurotropism.Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood-brain links in Alzheimer's disease.Kinetic evaluation and test-retest reproducibility of [(11)C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.Keratan Sulphate, a complex Glycosaminoglycan with Unique Functional Capability.Two Feet on the Membrane: Uptake of Clostridial Neurotoxins.Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats.Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy.

P2860

Q28477672-9D355DD2-7C31-4FF7-AA21-D3CACFB9F5C9 Q28478633-269B0922-BA46-4C2D-B340-377022022BF1 Q28543500-A0347A01-F787-4CB0-8CA7-49D51D1995AE Q28550043-A4987E61-2CE4-40B9-B2BA-70AE8680DA27 Q29144205-CC52B0B7-B9DF-4088-8C5F-C5AED3F71A3B Q30435547-1FFE3154-0939-4E67-B02E-6E4EC94CFD62 Q30459951-1680BD26-D67A-4AE3-9B58-E39A51D614AF Q33710870-F5503528-40D8-46AA-A5FD-30E9531B81CB Q34084438-27B84982-92EC-44A8-BFEA-41CE079EA7F6 Q34361313-23EDA5BB-E0F2-4170-AA46-EDE9E02B433A Q35357221-00688D5B-6C88-470D-A2E7-7DBA7DE9F0B9 Q36032254-B77A7169-9FC7-4FD2-AFEB-98F2ED5C6ABA Q36318726-F5DCBA31-1536-46B6-AB2D-EC915F11EE30 Q36850576-089E0F2F-03D6-4699-90EF-35D0CF5A96CA Q37048562-B8572B71-0FEE-49DA-BB27-75893E55436F Q37092563-31A7186F-9A51-43E8-94A9-3EB93B315705 Q37593734-1B1F32A3-D383-4C62-AF5D-8865CC94621B Q37711589-F87B7DEF-6BA1-4B8B-9E23-4653043169AF Q38150436-12600290-8481-4BBB-8FCB-EA5574371F52 Q38162868-B01BDB2C-E0C8-4E71-8F5B-80E2DADDA239 Q38189350-44399DDF-3EE9-4D78-B264-C4688E68FB73 Q38456313-1F804DCA-1AF7-425F-8FCF-4FBE09BFD8C9 Q39339952-368882BC-9650-4B97-9D26-D482F08833D6 Q40442773-E9BDCD63-DB99-4DA4-912B-1D7CB021583B Q41571892-072F50C1-C32C-4F80-A7C0-C15978487656 Q41928819-76619494-CD96-4B41-B113-E2AB38519855 Q45867306-9439DA2B-BF02-4D1F-A3F6-763EB437728C Q47814823-1C725D8E-99DE-48E5-B6E1-EC5130E6E635 Q47860795-45ADC557-822D-4A56-BC51-650F6C87A57F Q48026258-D56A0225-AB01-40C6-830D-6FCA169FB4F3 Q48258054-AC3AA040-58AB-44CE-A2B1-C9BE82B3C1A5 Q48383809-DCF7B8B4-E0FE-4B29-908D-936D760F618F Q51148309-0835614E-63EE-4CFF-9C7B-6F8D1F83CD54

P2860

SV2 regulates neurotransmitter release via multiple mechanisms.

http://www.wikidata.org/entity/Q34304904

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

SV2 regulates neurotransmitter release via multiple mechanisms.

@ast

SV2 regulates neurotransmitter release via multiple mechanisms.

@en

SV2 regulates neurotransmitter release via multiple mechanisms.

@nl

type

label

SV2 regulates neurotransmitter release via multiple mechanisms.

@ast

SV2 regulates neurotransmitter release via multiple mechanisms.

@en

SV2 regulates neurotransmitter release via multiple mechanisms.

@nl

prefLabel

SV2 regulates neurotransmitter release via multiple mechanisms.

@ast

SV2 regulates neurotransmitter release via multiple mechanisms.

@en

SV2 regulates neurotransmitter release via multiple mechanisms.

@nl

P1433

Q34304904-7A618548-FC50-409A-B2EC-B324DB2E42DC

P1476

Q34304904-DDC6093A-298C-453C-81A2-B988BA08B829

P2093

Q34304904-0BD78C8D-5B61-46C1-B183-EF89CD7093A6

Q34304904-990E38F4-6E7E-44C4-BB40-2965A364BE8B

Q34304904-D136AB87-454A-4CF6-B91C-252551A3770D

Q34304904-E074C161-3AC2-4FA5-B978-1ADACC0AA028

P2860

Q34304904-0894066D-A170-4C20-877F-A1534E488934

Q34304904-09DABD99-C386-4D5B-BD13-84D5D35696A7

Q34304904-0B5D0F2A-F290-4B08-B0E0-A8CF1331D0A5

Q34304904-0C90A661-2671-4C16-9458-EFF3FA3333F9

Q34304904-10AA66EB-EAB3-4F2C-942F-334B73600FD5

Q34304904-17EC4C6D-C2A4-4E7D-85B3-DC5D4503FF5D

Q34304904-1FD6721B-055B-427F-B6F3-B6FEEC28528E

Q34304904-24DDC68C-2923-4F56-8BD1-A384E0C779CC

Q34304904-25123430-7062-416C-A4CC-3AE8F8D02F98

Q34304904-25F91021-2319-4696-9391-EB32CF1DF4BF

P304

Q34304904-D8DCEBE5-6CAB-4675-B9CB-C97F75C26E09

P31

Q34304904-ACA59C76-108A-4B07-B712-0B95411E91BA

P356

Q34304904-BDD672E3-CAA4-4C3D-9AF2-F5A52B54A0A6

P433

Q34304904-3ECFB1A3-B787-4F34-B39E-D7FD5F9C9E60

P478

Q34304904-BA47338D-DC29-41E7-ADC6-8DBD3E165970

P577

Q34304904-A9E41817-2B96-46E4-A68E-4646527D83AD

P5875

Q34304904-217CBA19-E234-4541-A746-744B7888CE07

P698

Q34304904-2087C6B2-7964-4E22-9DD9-E241DECE9EC4

P921

Q34304904-B9E4973F-3219-4F7A-8AFD-F2E939697A96

P932

Q34304904-BD3FB6A8-F0CC-45CD-B7CB-16F39C3F76E3

P356

AJPCELL.00259.2010

P1433

American Journal of Physiology - Cell Physiology

P1476

SV2 regulates neurotransmitter release via multiple mechanisms.

@en

P2093

Amy Nowack

http://www.w3.org/2001/XMLSchema#string

Jia Yao

http://www.w3.org/2001/XMLSchema#string

Kenneth L Custer

http://www.w3.org/2001/XMLSchema#string

Sandra M Bajjalieh

http://www.w3.org/2001/XMLSchema#string

P2860

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Brain contains two forms of synaptic vesicle protein 2

Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)

SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis

Synaptotagmin I functions as a calcium regulator of release probability

Seletracetam (UCB 44212)

Synaptic vesicle protein 2 enhances release probability at quiescent synapses

SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release

SV2, a brain synaptic vesicle protein homologous to bacterial transporters

SVOP, an evolutionarily conserved synaptic vesicle protein, suggests novel transport functions of synaptic vesicles

P304

C960-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPCELL.00259.2010

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

299

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45629594

http://www.w3.org/2001/XMLSchema#string

P698

20702688

http://www.w3.org/2001/XMLSchema#string

P921

neurotransmitter

P932

2980308

http://www.w3.org/2001/XMLSchema#string